Neurogene (NGNE) Operating Margin (2019 - 2025)
Historic Operating Margin for Neurogene (NGNE) over the last 5 years, with Q1 2025 value amounting to 32398.75%.
- Neurogene's Operating Margin rose 292793100.0% to 32398.75% in Q1 2025 from the same period last year, while for Sep 2025 it was 121637.5%, marking a year-over-year increase of 1451130400.0%. This contributed to the annual value of 8930.27% for FY2024, which is N/A changed from last year.
- Latest data reveals that Neurogene reported Operating Margin of 32398.75% as of Q1 2025, which was up 292793100.0% from 2176.65% recorded in Q2 2024.
- In the past 5 years, Neurogene's Operating Margin registered a high of 434500.0% during Q1 2023, and its lowest value of 2176.65% during Q2 2024.
- For the 3-year period, Neurogene's Operating Margin averaged around 116960.38%, with its median value being 17759.09% (2025).
- In the last 5 years, Neurogene's Operating Margin plummeted by 2000000000bps in 2024 and then surged by 292793100bps in 2025.
- Neurogene's Operating Margin (Quarter) stood at 434500.0% in 2023, then crashed by -101bps to 2176.65% in 2024, then skyrocketed by 1588bps to 32398.75% in 2025.
- Its Operating Margin stands at 32398.75% for Q1 2025, versus 2176.65% for Q2 2024 and 3119.44% for Q1 2024.